Hopp til hovedinnhold

Pankreaskreft

Sist oppdatert: Sist revidert:
Sist revidert av:


Definisjon:
Adenokarsinom i pankreas av ukjent årsak
Forekomst:
Rundt 7 nye tilfeller per 100 000 per år på verdensbasis både hos kvinner og menn
Symptomer:
Ofte vage og uspesifikke med vekttap, magesmerter og ernæringsproblemer
Funn:
Kommer sent med bl.a. anemi, ikterus, vekttap, oppfylning
Diagnostikk:
CT-abdomen, ev. ultralyd kan stille diagnosen
Behandling:
Dersom tumor vurderes som resektabel, er primærbehandlingen kirurgisk
  1. Bond-Smith G, Banga N, Hammond TM, Imber CJ. Pancreatic adenocarcinoma. BMJ 2012;344:e2476. BMJ (DOI)  
  2. Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet 2016; 388: 73–85.
  3. De La Cruz MS, Young AP, Ruffin MT. Diagnosis and management of pancreatic cancer. Am Fam Physician. 2014 Apr 15;89(8):626-32. PMID: 24784121. PubMed  
  4. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014 Sep 11;371(11):1039-49. pmid: 25207767 PubMed  
  5. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med pankreaskreft. Helsedirektoratet 7/2021. www.helsedirektoratet.no  
  6. Kreftregisteret. Cancer in Norway 2020. Oslo: Kreftregisteret, 2021, www.kreftregisteret.no.
  7. Gaddam S, Abboud Y, Oh J, et al. Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018. JAMA 2021. doi:10.1001/jama.2021.18859 DOI  
  8. Schmidt-Hansen M, Berendse S, Hamilton W. Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. Pancreas 2016; 45: 814–8.
  9. Araghi M, Galanti R, Lundberg M, et al. Use of moist oral snuff (snus) and pancreatic cancer: Pooled analysis of nine prospective observational studies. Int J Cancer. 2017 Aug 15;141(4):687-693. PMID: 28486772. PubMed  
  10. Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Seminar. Lancet 2011; 378: 607-20. PubMed  
  11. Alsamarrai A, Das SL, Windsor JA, Petrov MS. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2014;12(10):1635–44.e5.
  12. Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer. A meta-analysis of cohort studies. Eur J Cancer 2011; 47: 1928-37 PubMed  
  13. Gapstur SM, Jacobs EJ, Deka A, et al. Association of alcohol intake with pancreatic cancer mortality in never smokers. Arch Intern Med 2011; 171: 444-51. PubMed  
  14. Hidalgo M. Pancreatic cancer. Review article. N Engl J Med 2010; 362: 1605-17. pmid: 20427809 PubMed  
  15. Aykut B, Pushalkar S, Chen R, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 2019; 574: 264-7. pmid:31578522 PubMed  
  16. Mortensen MB, Svolgaard B, Vyberg M. Diagnostik og udredning af cancer pancreatis. Ugeskr Læger 2010; 172: 1369. pmid: 20444407 PubMed  
  17. Wong JC, Lu DS. Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol. 2008;6(12):1301–1308. pmid: 189448228 PubMed  
  18. De Gaetano AM, Rufini V, Castaldi P, Gatto AM, Filograna L, Giordano A, et al. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdom Imaging 2012; 37: 983–1003.
  19. Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16(7):1727–1733. pmid: 19396496 PubMed  
  20. Warshaw AL, Lillemoe KD, Fernandez-Del Castillo C. Pancreatic surgery for adenocarcinoma. Curr Opin Gastroenterol 2012;28(5):488–93.
  21. Burcharth F. Cancer pancreatis 2010. Ugeskr Læger 2010; 172: 1355. pmid: 20444402 PubMed  
  22. Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006;(2):CD004200. The Cochrane Library  
  23. Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 2011; 3: CD007519. Cochrane (DOI)  
  24. Neoptolemos JP, Palmer DH, Ghaneh P. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017 Jan 24. pii: S0140-6736(16)32409-6. pmid: 28129987 PubMed  
  25. Kristensen A, Vagnildhaug OM, Grønberg BH et al. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Crit Rev Oncol Hematol 2016; 99: 286-98. pmid:26819138 PubMed  
  26. Liao W-C, Tu YK, Wu MS, et al. Blood glucose concentration and risk of pancreatic cancer: Systematic review and dose-response meta-analysis. BMJ 2015 Jan 3; 349:g7371. pmid: 25556126 PubMed  
  27. Hoem D, Viste A. Improving survival following surgery for pancreatic ductal adenocarcinoma - a ten-year experience. Eur J Surg Oncol 2012; 38: 245-51. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim
  • Silje Folven Barlindhaug, spesialist allmennmedisin, redaktør NEL

Tidligere fagmedarbeidere

  • Hermod Petersen, professor og overlege, Norges teknisk-naturvitenskapelige universitet og Medisinsk avdeling, Regionsykehuset i Trondheim
  • Jon Erik Grønbech, professor Norges teknisk-naturvitenskapelige universitet og overlege Kirurgisk avdeling, Regionsykehuset i Trondheim